Medical News: ACR: Safety of TNF Inhibitors Tops Meeting Agenda …
October 31st, 2009
| Tags: add new tag, britain, british, drug, facebook, medical, primary, safety, three-word-title
A one-year, placebo- controlled trial of the drug in rheumatoid arthritis patients with an inadequate response to methotrexate failed to show significant improvement in radiographic progression relative to placebo, according to one abstract to … Patients with osteoarthritis of the knee taking glucosamine in the randomized 24-week trial had the same rate of radiographic disease progression as a placebo group
See the original post here:
Medical News: ACR: Safety of TNF Inhibitors Tops Meeting Agenda …
Leave a comment
| Trackback